==== Front Iran J Basic Med Sci Iran J Basic Med Sci IJBMS Iranian Journal of Basic Medical Sciences 2008-3866 2008-3874 Mashhad University of Medical Sciences Mashhad, Iran 10.22038/IJBMS.2023.65997.14512 Review Article The effects of Dendrobium species on the metabolic syndrome: A review Oskouei Zahra 1 Ghasemzadeh Rahbardar Mahboobeh 2 Hosseinzadeh Hossein 12* 1 Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran 2 Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran * Corresponding author: Hossein Hosseinzadeh. Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. Tel: +98-51-38819042; Fax: +98-51-38823251; Email: hosseinzadehh@mums.ac.ir 2023 26 7 738752 9 6 2022 1 2 2023 https://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Metabolic syndrome (MetS) is known as a global health challenge with different types of health conditions such as hypertension, hyperglycemia, the increasing prevalence of obesity, and hyperlipidemia. Despite much recent scientific progress, the use of traditional herbal medicines with fewer side effects is increasing worldwide. Dendrobium, the second-largest orchid genus, has been used as a natural source of drugs for the treatment of MetS. The beneficial effects of Dendrobium, including anti-hypertension, anti-hyperglycemia, anti-obesity, and anti-hyperlipidemic against MetS have been shown in the scientific evidence. The anti-oxidant and lipid-lowering effects of Dendrobium modulate hyperlipidemia via reducing lipid accumulation and maintaining lipid metabolism. Restoring pancreatic beta cells and regulating the insulin signaling pathway are involved in its antidiabetic properties. The hypotensive effects contribute to increasing nitric oxide (NO) generation and inhibiting extracellular signal-regulated kinase (ERK) signaling. More research projects, especially clinical trials, are needed to investigate the safety, efficacy, and pharmacokinetics of Dendrobium in patients. This review article provides, for the first time, comprehensive information about the efficacy of different species of Dendrobium. The described species can be a source of medicines for the treatment of MetS, which are reported in various evidence. Key Words Dendrobium Diabetes Dyslipidemia Hypertension Metabolic syndrome ==== Body pmcDiscussion Nowadays, metabolic syndrome (MetS) affects more than a billion people worldwide (1) and in both developed and developing countries, some factors, including industrial lifestyle, unhealthy diet, and high levels of stress have resulted in a higher prevalence of MetS (2). MetS is a serious problem defined as a group of disorders including hypertension (3), obesity, hyperlipidemia (4), insulin resistance, glucose intolerance (5), fatty liver (6), low levels of high-density lipoprotein (HDL), and high blood amounts of triglycerides (TG) (7), which increases the prevalence of type 2 diabetes mellitus (T2DM) and cardiovascular risk factors (8). On the other hand, due to inadequate efficiency complications for this proceeding disorder, researchers have focused attention on the use of medicinal plants. Some of these plants and their active constituents are effective in the treatment of MetS, including Nigella sativa (9), Camellia sinensis (10), Silybum marianum (11), Persea americana (12), Crocus sativus L. (13), Garcinia mangostana (14), Capsicum annuum (15), Vitis vinifera (16), Berberis vulgaris (17), rutin (18), and Solanum melongena (19). Orchidaceae is a diverse family of flowering plants with about 27,800 species (20). Among several orchid species, Dendrobium is identified as the most popular and largest orchid genera (21). The genus Dendrobium contains almost 1400 species, which are found in Australia, the Pacific Islands, and Asia (22). Also, there are morphological differences among various species of Dendrobium. In some species, flowers appear in pairs or threes on a peduncle along the entire length of the pseudobulbs, with caduceus-like leaves. In some groups, small flowers arise from leaf axils, while the flowers are paired up or alternately closely set to form pendants or erect thyrses in another species (23). Moreover, the Dendrobium genus, approximately 74 species of which have been distributed in China’s tropical and subtropical regions, has been used as a herbal medicine in the treatment of symptoms of diseases such as increasing the production of body fluids, nourishing the stomach, reducing throat inflammation, and improving eyesight for thousands of years (24, 25). Previous research projects have shown that Dendrobium contains components such as alkaloids, flavonoids, bibenzyls, terpenes, phenanthrenes, steroids, lignans, and polysaccharides that have important pharmacological properties (26, 27). According to studies (28, 29), the most relevant phytochemical elements of Dendrobium species in metabolic syndrome include polysaccharides, alkaloids, and polyphenols. The bioactive constituents of Dendrobium include gigantol, moscatilin, dendrofalconerol A, dendrochrysanene, cripidatin, confusarin, denbinobin, and chrysotobibenzyl are shown in Figure 1. According to previous evidence, Dendrobium showed various pharmacological properties, including anti-inflammatory (30, 31), anti-fungal (32), antimicrobial (33), anti-oxidant (34-36), antidiabetic (37, 38), hepatoprotective (39, 40), anti-hyperglycemic (29, 41, 42), anti-insulin resistance (43, 44), anti-hypertensive (45, 46), and anticancer (47, 48) (Table 1). Also, the effect of D. officinale on MetS has been determined in Figure 2. Regarding the data in hand, this review aims to highlight the beneficial and potential properties of Dendrobium on MetS and its complications. Methods The information was collected by searching PubMed, the Web of Science, Google Scholar, and Scopus. These data have been gathered in the English language, with no time limitation. All types of related books, articles, and abstracts were included. The search keywords included “anti-hyperglycemic”, “antihypertensive”, “antidiabetic”, “atherosclerosis”, “obesity”, “blood pressure”, “blood glucose”, “Dendrobium”, “diabetes”, “dyslipidemia”, “high cholesterol”, “hypercholesterolemia”, “hyperglycemic”, “hyperlipidemia”, “body mass index”, “waist circumference”, “hypertension”, hypertriglyceridemia”, “hypoglycemic”, “hypotensive”, “insulin”, “insulin-resistance”, “metabolic syndrome”, “triglyceride”, “atherogenic” and “ weight loss”. Effect of Dendrobium on diabetes Diabetes mellitus, as a significant global health threat, is a cluster of MetS identified with hyperglycemia and destruction of cellular resistance to both insulin and insulin secretion (49). Insulin resistance is characterized by a reduction of the appropriate response to insulin stimulation, glycogen synthesis, and lipid oxidation. Insulin resistance also has a critical impact on the pathogenesis of MetS, including T2DM and obesity (50, 51). Diabetes is a leading cause of macro-vascular and microvascular complications and dramatically increases the risk for nephropathy, retinopathy neuropathy, and cardiovascular diseases (CVDs) (52, 53). Hyperglycemia is closely related to the excess generation of reactive oxygen species (ROS) and oxidative stress which can up-regulate the levels of inflammatory factors including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6) and reduces the level of interleukin 10 (IL-10). Moreover, TNF-α induces insulin resistance and hyperlipidemia by activating nuclear factor-κB (NFĸB) (54). Different molecular mechanisms such as α-glucosidase activity associated with hyperglycemia have been identified. Inhibition of this enzyme can significantly delay carbohydrate absorption and decrease the postprandial elevation of blood glucose levels after meals (55). Cyclic adenosine monophosphate protein kinase A (cAMP/PKA) can regulate glucose homeostasis in several processes, including glucose uptake, glucagon and insulin secretion, gluconeogenesis, glycogenesis, and glycogen degradation (56). The roles of peroxisome proliferator-activated receptor-α (PPAR-α) in mediating diabetes-related molecular events and increasing insulin secretion via regulating fat and β-oxidation of adipocytes in islet β cells have been explored (57). Also, the glucagon-like peptide-1 (GLP-1) secreted by intestinal L cells participates in promoting insulin release and inhibiting glucagon secretion (58). In some studies, the antidiabetic properties of different species of Dendrobium, including D. officinale, D. huoshanense, D. loddigesii, D. officinale, D. candidum, D. formosum Roxb. ex Lind, D. mixture, D. gibsonii, D. moniliforme, and D. nobile Lindl. have been reported and will be discussed in the following. In vitro studies In a study, the mechanism of hypoglycemic effects of D. tortile Lindl. was determined in vitro by its α-glucosidase inhibitory activity. In this study, the ethyl acetate extract from the whole D. tortile Lindl. resulted in the isolation of compounds such as dendrofalconerol A, which at the concentration of 200 µg/ml, similar to acarbose (antidiabetic medicine) showed strong α-glucosidase inhibition (59). Inhibitory impacts on α-amylase and α-glucosidase enzyme activities have been shown in another study. D. officinale constituents exhibited an antidiabetic effect by inhibition of radical scavenging response, α-glucosidase, and α-amylase. Among various compounds that were identified from the crude extract of stem of D. officinale, 3,4-dihydroxy-4, 5-dimethoxybibenzyl reported as an α-glucosidase, an α-amylase inhibitor and radical scavenging agent for the first time (60). In another study, the hypoglycemic effect of a shihunine-rich extract of a D. loddigesii was investigated on 3T3-L1 cells. In this research, insulin resistance was induced in 3T3-L1 adipocytes by dexamethasone which resulted in decreased glucose uptake. D. loddigesii (1.02, 2.03, 4.06, 8.12, and 16.25 µg/ml) treatment significantly raised glucose uptake while reducing the raised level of insulin resistance in 3T3-L1 cells (61). D. devonianum and its constitutes including A flavonol glycoside (5-hydroxy-3-methoxy-flavone-7-O-(β-D-apiosyl-(1-6) -βD-glucoside), as well as gigantol showed hypoglycemic effects via inhibiting of the α-glucosidase enzyme with the inhibition rate of 43.4% and 36.7%, respectively (62). In an in vitro model, the various concentrations of polysaccharides from D. officinale (100, 200, and 400 μg/ml) ameliorated glucose metabolism by regulating the phosphatidylinositol 3 kinase/protein kinase B (PI3K/AKT) signaling pathway which shows an important impact on glycogen synthesis and glucose metabolism in IR HepG2 cells. Besides, the expression of p-PI3K, PI3K, p-Akt, Akt, p-IRS1, p-IR-β, IR-β, and IRS1 in IR HepG2 cells was reduced compared to the control group. By treatment of polysaccharides from D. officinale for 24 h, the expression of these proteins significantly increased (63). Two polysaccharides from the stems of D. officinale were isolated, and their hypoglycemic activity was evaluated in the murine enteroendocrine cell line (STC-1). In this study, the polysaccharides from D. officinale at various concentrations (0, 0.2, 2, 20, 200, and 2000 μg/ml) showed a significant hypoglycemic effect by inducing glucagon-like peptide-1 (GLP-1) secretion in STC-1 cells (64). In a study, a methanol extract from the whole plant of D. formosum Roxb. ex Lindl. resulted in the isolation and identification of various compounds, such as moscatilin which at the concentration of 100 µg/ml concerning glucose-uptake stimulation effects, showed greater activity than insulin on L6 myotubes. Also, the glucose uptake stimulation effect was shown at a non-toxic concentration of lusianthridin (1 µg/ml) on L6 myotubes cells. Moreover, methoxy-7-hydroxy-9,10-dihydro-1,4-phenanthrenequinone (50 µg/m) reduced hyperglycemia via inhibiting both pancreatic lipase and α-glucosidase enzymes (65). Inhibitory effects on α-glucosidase enzyme activities have been observed in another study. In this experiment new compound, dendrogibsol, which was isolated from the whole plant of D. gibsonii exhibited potent α-glucosidase inhibitory activity at the dose of 100 µg/ml as compared with the positive control acarbose (66). To evaluate the antidiabetic and anti-oxidant effects of polysaccharides from D. chrysotoxum Lindl., an in vitro study was performed on mouse splenocytes and Jurkat cells (MCF-7). In this experiment, polysaccharides were isolated from the stem of D. chrysotoxum Lindl. and showed potent anti-oxidant and hypoglycemic effects in Jurkat cells. Since the anti-oxidant potential of polysaccharides plays an effective role in preventing the development of diabetes, the beneficial effect of D. chrysotoxum Lindl. polysaccharides in treating diabetic patients may be related to their anti-oxidant property (29). In another study, the polysaccharides from D. officinale exhibited hypoglycemic activity by inhibiting hepatic gluconeogenesis, glycogen degradation, and ameliorating the liver glucose metabolism in diabetic mice (67). In vivo studies To assess the hypoglycemic effects of the polysaccharide GXG, which was extracted from the stems of D. huoshanense, the T2DM mouse model was established. In this study, intragastric administration of the polysaccharide GXG (50 mg/kg/day and 200 mg/kg/day for 5 weeks) showed hypoglycemic effects via regulating glucose homeostasis in T2DM mice. On the other hand, D. huoshanense polysaccharide GXG could normalize hyperglycemia and increase the number of β-cells by reducing β-cells apoptosis in the pancreatic islets. Furthermore, it was suggested that GXG may protect against T2DM via regulating the insulin signaling pathway and multiple steps of the PI3K/AKT action in streptozotocin (STZ) and a high-fat diet (HFD) treated mice (25). In another experiment, the antidiabetic activity of the rich-polyphenol extract of D. loddigesii (25, 50, and 100 mg/kg, gavage, 8 weeks) was evaluated in diabetic db/db mice. These results showed that D. loddigesii (100 mg/kg) demonstrated a decreasing impact on blood sugar levels and insulin resistance in diabetic mice. Also, D. loddigesii and its phenols components showed anti-inflammatory properties via reducing the levels of IL-6 and TNF-α proteins and anti-oxidant effects by elevating the levels of biochemical enzymes such as catalase (CAT), superoxide dismutase (SOD), as well as glutathione (GSH) (68). The antidiabetic effects of polysaccharides from D. officinale stem (20, 40, 80, and 160 mg/kg for 4 weeks) on T2DM rats have been verified in another study. Blood glucose, the serum level of insulin, and glycated serum protein decreased. Polysaccharides from D. officinale may activate the anti-oxidant response, which is important for alleviating liver metabolic syndrome and lipid peroxidation (37). Liu et al. investigated the antidiabetic effects of polysaccharides from D. officinale and observed that an intraperitoneal administration of the ethanolic extract of the stem (100, 200, and 400 mg/kg, 4 weeks) to STZ-HFD-induced diabetic mice ameliorated hyperglycemia and hepatic glucose metabolism through regulating the liver-glycogen structure and glucagon-mediated signaling pathways. D. officinale showed an increase in liver glycogen synthesis, suppressed hepatic gluconeogenesis, and decreased breakdown of glycogen. The results suggested that the regulatory mechanism of these effects may be regulating hepatic glycogen metabolism via the cyclic adenosine monophosphate protein kinase A (cAMP-PKA) signaling pathway in HFD/STZ-induced T2DM mice (67). The hypoglycemic properties of water-soluble D. officinale from the dry stem (75, 150, and 300 mg/kg, 12 weeks, IP) were investigated in diabetic mice. D. officinale showed a decrease in the amount of serum fasting insulin (FINS) in mice with diabetic cardiomyopathy. It also increased the expression of PPAR-α and decreased the expression of transforming growth factor-β1 (TGF-β1). This finding suggested that D. officinale ameliorated HFD/STZ-induced diabetic cardiomyopathy. A significant decrease in phosphorylation of JNK, an increase in phosphorylation of insulin receptor substrate 1 (p-IRS1), and E-cadherin, known as the epithelial cadherin, by D. officinale were observed. Moreover, it was suggested that the possible mechanism for D. officinale extract function may be in connection with the activation of the PPAR-α/c-Jun N-terminal kinase (JNK) pathway (69). Inflammation and insulin resistance are mediated by the inhibition of serine phosphorylation of IRS-1 by JNK (70). Chang et al. investigated the functional antidiabetic role of D. candidum (0.2, 0.4, and 0.8 g/kg, two weeks, IP) on kidneys in diabetic rats. In this study, D. candidum played a reno-protective role against diabetic conditions by inhibiting the expression of biological factors including connective tissue growth factor (CTGF), glucose transporter-1 (GLUT-1), and vascular endothelial growth factor (VEGF). Also, D. candidum demonstrated important antidiabetic effects under diabetic problems via decreasing the levels of clinical prognosis factors for kidney function such as urea, serum creatinine, and urea nitrogen in blood (71). From data obtained in a study, D. mixture (12 g/kg, 8 weeks, gavage) significantly decreased the fasting blood glucose (FBG) and improved diabetic nephropathy via reducing the expression transforming growth factor-β1 (TGF-β1)/Smads signal transduction pathway in db/db mice (72). The hypoglycemic effects of D. officinale Kimura et Migo in treating diabetic nephropathy were evaluated in another study. According to these results, D. officinale (5 and 10 ml/kg, intragastric, for 4 weeks) demonstrated therapeutic potential effects via reducing the activation of FBG, FINS, insulin-resistant, and toll-like receptors (TLRs) in diabetic rats induced by STZ (43). The anti-diabetic activity of an aqueous extract from D. officinale Kimura & Migo was investigated in an experiment. In this study, high-dose water extract of D. officinale (700 mg/kg, 2 weeks, IP) demonstrated a considerable reduction in random blood glucose levels, while no significant difference was found in the low-dose water extract (350 mg/kg, 2 weeks, IP) group. However, this plant increased the FINS serum in all doses (73). In diabetic rats, exposure to D. mixture at the dose of (17.2 g/kg/day, 12 weeks, IP) caused a reduction in FBG, aspartate transaminase (AST) glycosylated serum protein (GSP), and alanine transaminase (ALT). A positive correlation between increased levels of ALT and decreased insulin sensitivity in the liver can be used to predict the development of T2DM. In this study, D. mixture decreased the expression of proteins such as glucose‐6‐phosphatase (G6Pase), phosphoenolpyruvate carboxykinase (PEPCK), and signaling molecule Forkhead box O (FoxO1) by increasing the activity of PI3K/ Akt, thereby regulated gluconeogenesis and glucose metabolism under diabetic condition (74). Another study revealed the beneficial hypoglycemic effects of polysaccharides from D. moniliforme (100 and 200 mg/kg, ig) on experimental diabetic mice. D. moniliforme extract significantly decreased the serum glucose level and elevated glucose tolerance in adrenalin and alloxan-induced diabetic mice (75). The hypoglycemic properties of the extracts from D. nobile Lindl. (10-80 mg/kg, 8 days, PO) were investigated in hyperglycemic mice induced by adrenalin. Polysaccharides and alkaloids in D. nobile Lindl. extract induced a reduction in the level of blood sugar in experimental mice (76). study by Zhang et al. indicated that oral administration of D. fimbriatum extracts at the doses of 100 and 200 mg/kg (orally, 2 to 5 weeks) significantly ameliorated diabetes symptoms via inhibiting the inflammatory factors such as cytokines IL-1β and TNF-α and preventing islet cell apoptosis in diabetic rats. This article proposed that regulatory mechanisms of this effect may regulate diabetes and its complications by preventing β-cells apoptosis and decreasing liver lipid accumulation (77). In another study, D. chrysotoxum Lindl. ameliorated diabetic retinopathy and retinal inflammation by inhibiting the NF-𝜅B signaling pathway. In this study, D. chrysotoxum Lindl. (30 and 300 mg/kg, orally, 4 weeks) could decrease retinal mRNA expressions of intercellular adhesion molecule-1 (ICAM-1) and the serum levels of inflammatory markers such as TNF-α, IL-6, and IL-1β by inhibiting NF-𝜅B activation in diabetic rats. NF-𝜅B family regulates inflammatory responses through the activity of cytokines such as IL-1β and TNF-α. D. chrysotoxum Lindl. also reversed the expression of tight junction proteins (including occludin and claudin-1) and alleviated the increased p65, inhibitor of nuclear factor kappa B (IκB), and IκB kinase (IKK) in diabetic rats. Therefore, D. chrysotoxum Lindl. ameliorated an inflammation of the retina by inhibiting the NF-𝜅B signaling pathway in STZ-induced diabetic rats (78). The anti-diabetic effect of polysaccharides from D. chrysotoxum Lindl. (200 and 500 mg/kg, orally, for 1 week) on alloxan-induced diabetic mice was evaluated. This compound decreased the level of blood glucose in all of the doses. Also, D. chrysotoxum Lindl. showed anti-oxidant activity by inhibiting hydroxyl radicals (OH)-mediated deoxyribose degradation and superoxide anions (O2• −) against glucose oxidase mediated cytotoxicity in Jurkat cells. Thus, these results suggest that D. chrysotoxum may exert hypoglycemic effects through anti-oxidant activity (29). In another study, administration of polysaccharides from D. huoshanense (50, 100, and 200 mg/kg, IP) decreased blood sugar levels in diabetic cataract rats. These compounds improved cataract diabetes by inhibiting the oxidation pathway, which down-regulated inducible nitric oxide synthase (iNOS) gene expression and advanced glycation end products (AGEs) formation (79). An in vivo study demonstrated the differences in hypoglycemic effects among various Dendrobium species on the metabolic syndrome. In these results, the oral administration (50, 100, and 200 mg/kg) of polysaccharides from D. officinale, D. nobile, and D. huoshanense indicated significant anti-diabetic effects. D. officinale, D. nobile, and D. huoshanense but not D. chrysotoxum showed anti-diabetic activity in the decreasing order of D. huoshanense > D. nobile > D. officinale > D. chrysotoxum (80). According to the above-mentioned results, the various species of Dendrobium at different doses (high doses and low doses) and times of exposure significantly decreased blood sugar levels through various mechanisms in diabetic study models. It seems inhibition of the NF-𝜅B signaling pathway, decreasing hydroxyl radicals, and increasing anti-oxidant activity are some of the most important mechanisms to manage the antidiabetic effects of these plants (Table 2). Effect of Dendrobium on serum lipid profile Hyperlipidemia normally refers to high levels of cholesterol, TG, and changes in lipoprotein patterns within the human body (81). Hyperlipidemia is also described as a lipoprotein metabolism disorder that leads to atherosclerosis, coronary artery disease and metabolic syndrome. Additionally, hyperlipidemia is known as an established risk factor for CVD disorder which is the leading cause of mortality worldwide (82). Among various mechanisms in lipid metabolism, PPAR-α has a crucial impact on lipid metabolic processes and accelerates β-oxidation of adipocytes in islet β cells (83). The JNK signaling pathway is also known to contribute to regulating the PPAR-α -FGF21 hormone (84). Fatty acid β-oxidation is another pathway for lipid metabolism that occurs in both mitochondria by carnitine palmitoyltransferase 1 (Cpt1) and peroxisomes by Acyl-CoA Oxidase 1 (Acox1) (85). Among the various herbal medicine compounds, Dendrobium species have been shown to have potent anti-dyslipidemia effects in different experimental models, which are discussed in the next sections. In vitro studies In a study, the stems of D. loddigesii (2.03, 4.06, 8.12, and 16.25 µg/ml) significantly decreased the intracellular accumulation of fat droplets and TG as well as promoted the 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2 deoxyglucose (2-NBDG) uptake of 3T3-L1 cells. D. loddigesii also revealed its lipid-lowering effect by increasing in p-AMPK and GLUT-4 levels in the adipose tissue and a rise in expression levels of p-AMPK and PPAR-γ in the liver tissue. Thus, it showed the hypolipidemic effects by up-regulating the expression of proteins such as PPAR, p-MAPK, and GLUT4 (61). The inhibitory effect of a polysaccharide compound (DHP1A) obtained from D. huoshanense (0.5, 0.1, 1.5, and 2.0 mg/ml) on the FeCl2-induced lipid peroxidation in mice’s liver was examined in vitro. According to these data, a variety of mechanisms, such as an increase in the levels of free radical scavenging including glutathione peroxidase (GPx), CAT, SOD, as well as GSH are involved in the reduced activity of dyslipidemia and MDA content. The anti-oxidant response of DHP1A was more remarkable than that of dextran under the same conditions; this may be due to its unique structural features. Also, it showed an inhibitory effect on the FeCl2-induced lipid peroxidation. Therefore, anti-lipid peroxidation essentially played a role in the anti-oxidant mechanisms of DHP1A (86). In vivo studies The anti-hyperlipidemia effects of water-soluble extracts of D. officinale (75, 150, and 300 mg/kg, 12 weeks, IP) have been studied in diabetic and HFD rats. In this study, D. officinale increased fatty acid metabolism, significantly decreased LDL-C, TC, FINS, and TG, and increased HDL-C levels in the serum. The possible mechanism of these effects may be associated with the expression activation of PPAR-α and a decrease in the expression of p-JNK proteins (69). In another experiment, ultrafine D. officinale powder (0.6 g/kg per day, 3 weeks, PO) regulated fatty acid metabolism to improve the accumulation of lipids in a mouse model of progressive nonalcoholic fatty liver disease (NAFLD) on the high-sucrose, high-fat (HSHF) diet. The positive correlation between fatty acid metabolism disorders and the development of NAFLD in liver injury has been confirmed. According to the results, D. officinale powder ameliorated liver lipid metabolism in NAFLD mice by reducing the levels of hepatic lipids, including TC, TG, triacylglycerol (TAGs), AST, ALT, and free fatty acid (FFA). Reduction in fatty acids synthesis, uptake, and desaturation, and promotion of FA β-oxidation were also observed after treatment with D. officinale powder (87). The results of a study on hyperlipidemic rats suggested that an aqueous extract from D. officinal showed an anti-hyperlipidemic effect at doses of 0.25, 0.5, or 1 g/kg by reducing the serum levels of ALT, AST, LDL-C, TG, and TC, as well as a significant elevation in the serum concentrations of HDL-C. Moreover, D. officinal inhibited the formation and development of high lipid profiles and enhanced anti-oxidant capacity in hyperlipidemic rats (88). Various studies have shown that hypercholesterolemia (HCD) is a variable risk factor that forms atherosclerosis plaques by increasing levels of lipid profiles. In an experiment, D. huoshanense polysaccharide inhibited plaque formation by decreasing lipid accumulation in the blood vessels of the AS zebrafish. Moreover, it showed a significant decrease in the levels of ROS, TC, TG, and malondialdehyde (MDA) in zebrafish (89). In another study, the hepatoprotective effect of different extracts (water extract, alcohol-soluble extract, alcohol-insoluble extract, and crude extract) of D. huoshanense was investigated on sub-acute alcohol-induced hepatic failure in mice. After administration of D huoshanense for 30 days, serum concentrations of AST, ALT, alkaline phosphatase (ALP), LDL-C, TC, and TG significantly decreased, and the activation of enzymes such as SOD, alcohol dehydrogenase (ADH), acetaldehyde dehydrogenase (ALDH) and glutathione (GSH-Px) in the liver increased. In this study, freeze-dried D. huoshanense, its water extract, and its alcohol-insoluble extract showed better protective effects than that of the alcohol-soluble extract against alcohol-induced liver damage and steatosis, but these effects were lower than those of crude polysaccharides (90). In a study, D. nobile Lindl. alkaloids (10–80 mg/kg, 8 days, PO) reduced hyperlipidemia by activating Acox1 and Cpt1a genes in mice fed with HFD. Furthermore, D. nobile Lindl. alkaloids improved metabolic liver diseases in animals via upregulating adipose triglyceride lipase (ATGL/Pnpla2), which was mediated by the activation of PPAR-α. Decreasing the expression of sterol regulatory element-binding protein 1 (Srebp1), as a mechanism of lipid-lowering, was another beneficial effect of D. nobile Lindl. alkaloids in the metabolic syndrome (76). The other experiments carried out to investigate the effect of the rich-polyphenol extract of D. loddigesii on lipid serum in diabetic mice confirmed the above-mentioned activities. In this study, D. loddigesii (25, 50, and 100 mg/kg, 8 weeks, gavage) showed a significant reduction in the levels of LDL-C, TC, and TG while increasing HDL-C blood serum levels (68). The results of a study on D. mixture (17.2 g/kg/day, 12 weeks, IP) in HFD and highsugar diet rats demonstrated a significant reduction in serum ALT, AST, and GSP levels. Moreover, a reduction in lipid profiles such as LDL-C, TC, and very-low-density lipoprotein cholesterol (VLDL-C) was noted, while the serum level of HDL-C increased (74). The hypolipidemic effects of D. candidum Wall. ex Lindl. (200 or 400 mg/kg, 6 weeks, i.g.) were evaluated on mice with HFD. D. candidum decreased lipid accumulation and maintained lipid metabolism and glucose homeostasis. Accordingly, D. candidum significantly inhibited the hepatic inflammasome activation of the NLR family pyrin domain containing 3 (NLRP3) and elevated the expression of gluconeogenesis-related genes and lipid metabolism in HFD mice. The results indicated that this plant may be a useful therapeutic strategy against NAFLD damage (40). Different spices of Dendrobium demonstrated a significant reduction in serum levels of lipid profiles. These findings are supported by various studies that Dendrobium decreased the levels of LDL-C, TC, and TG while it increased HDL-C blood serum levels. In addition, Dendrobium species through other mechanisms such as anti-oxidant activity, increase in expression of PPAR-α, and decrease in expression of p-JNK proteins showed hypolipidemic effects at the different doses and times of exposure (Table 3). Effect of Dendrobium on high blood pressure Hypertension is a very common condition that leads to an increase in the incidence of CVD, myocardial infarction, stroke, ischemia, and atherosclerosis (91-93). This phenomenon is a progressive medical condition that is prevalent in the world and causes premature mortalities (94). Blood pressure leads to increased post-cardiac load and cardiovascular dysfunction, resulting in compensatory cardiac hypertrophy (95). Although antihypertensive therapy has been used for many years to decrease the risk of morbidity and mortality, the side effects of these drugs, including calcium channel inhibitors and angiotensin-converting enzyme blockers tend to decrease medication adherence. Therefore, natural compounds with fewer side effects and potential anti-hypertensive therapeutic values are used to treat elevated blood pressure (96). Several studies have demonstrated the anti-hypertension effect of various species of Dendrobium via different mechanisms, which are discussed in the next sections. In vitro studies In an in vitro model, the aqueous extract of D. candidum (2 mg/ml) improved cardiac hypertrophy by regulating the extracellular signal-regulated kinase (ERK) signaling pathway in the rat cardiac myocyte H9c2 cells incubated with isoproterenol. According to the results, D. candidum lowered the up-regulated mRNA expression levels of brain natriuretic peptide (BNP) and ANP induced by isoproterenol by inhibition of the ERK pathway (97). In vivo studies The beneficial effects of the Dendrobium compound in preventing blood pressure were investigated using hypertensive rats. This agent was mixed with diet and fed to the rats for 4 weeks. Results showed that the D. candidum compound (1.65, 3.30, and 5.00 g/kg) significantly reduced the blood pressure and exhibited anti-hypertensive activity by activating PI3K/AKT/endothelial nitric oxide synthase (eNOS) signaling pathways and increasing the levels of serum nitric oxide (NO) generation. Besides, this plant significantly prevented hypertension and vascular dysfunction in hypertensive rats by inhibiting the secretion of ICAM-1 and the levels of serum endothelin-1 (ET-1) (98). The antihypertensive effect of D. officinale flos was evaluated on hypertensive rats caused by high-fat and glucose compound alcohol. In this study, D. officinale flos (3, 1 g/kg for 6 weeks) normalized systolic blood pressure, mean arterial pressure, and improved vascular diastolic dysfunction. Also, this plant reduced the plasma content of ET-1, thromboxane B₂ (TXB₂), and thickening of the thoracic aorta, while the levels of prostacyclin (PGI₂), NO, and the activities of vascular endothelial cells increased (99). In a study, D. officinale granules improved hypertension in hypertensive rats induced by long-term alcohol. This agent was fed to the rats for 32 weeks and not only decreased hypertension (mean blood pressure and systolic and diastolic hypertension) but also showed notable improvement in the lipid profile besides liver and kidney injuries (100). In an experiment, the aqueous extracts of D. candidum (0.13 and 0.78 g/kg, orally, for 4 weeks) alleviated cardiac hypertrophy and improved heart function in isoproterenol-induced cardiac hypertrophy models through inhibition of the ERK signaling pathway. It is worth noting that D. candidum prevented cardiac hypertrophy by reducing the left ventricular systolic pressure (LVSP), heart-to-body weight ratio (HW/BW), left ventricular/tibia length (LV/TL), and atrial natriuretic peptide (ANP) (97). In a study, D. officinale Kimura et Migo (5 and 10 ml/kg, intragastric< for 4 weeks) significantly reduced hypertension in rats with diabetic nephropathy (43). In another experiment, the antihypertensive effects of D. officinale in another experiment were investigated. In this study, D. officinale showed protective effects against high blood pressure by triggering the enteric-origin short-chain fatty acid- G-protein-coupled receptors (SCFA-GPCR43/41) pathway in metabolically hypertensive rats (101). Therefore, these results suggest that different species of Dendrobium such as D. candidum and D. officinale through inhibition of the ERK signaling, reduction in plasma content of ET-1, TXB₂, and thickening of the thoracic aorta, increase the levels of PGI₂, NO and the activities of vascular endothelial cell demonstrated hypotension effects in experimental models (Table 4). Effect of Dendrobium on obesity Obesity is a critical global issue, and its prevalence is increasing in both developed and developing countries (102). It is considered the fifth leading risk factor for mortality according to the World Health Organization (WHO) and greatly increases the risk of chronic diseases including diabetes, CVD, cancer, neurodegenerative diseases, rheumatoid arthritis, and osteoarthritis (103, 104). Obesity is a state of pathological increase in the amount of adipose tissue, which is closely associated with an imbalance between food intake and energy expenditure (105). Disorders in the secretion of adipokines, specific cytokines of adipocytes in the obese state, result in changes in lipid and carbohydrate metabolism and may lead to insulin resistance and diabetes (103). PPAR-γ has been reported to play an important role in the regulation of lipid metabolism in adipocytes through fatty acid trapping (106). Obesity-related diseases may be effectively treated by preventing or treating insulin resistance and abnormal lipid metabolism. Few studies have investigated the use of natural products to treat obesity, such as Dendrobium, which has demonstrated promising anti-obesity properties in several reports. In vitro studies The inhibitory effect of the D. officinale polysaccharide (200 μg/ml for 48h) was assessed on palmitic acid-induced insulin resistance in 3T3-L1 adipocytes, C2CL2 myocytes, and hepatocytes. The results showed that D. officinale treatment significantly promoted the insulin-stimulated glucose uptake of 3T3-L1 adipocytes and C2C12 myocytes, while the glucose output of hepatocytes decreased. Therefore, it is likely that D. officinale is an agent with potential therapeutic or preventive effects against insulin resistance. According to these results, D. officinale improved the expression of PPAR-γ in myocytes, adipocytes, and hepatocytes (107). In vivo studies The protective effect of D. moniliforme extract (200 mg/kg, orally, for 9 weeks) on obesity-induced renal damage in HFD mice was investigated. In this study, D. moniliforme showed a lipid-lowering effect in HFD-induced obesity in mice. Furthermore, after D. moniliforme extract administration, the increased body weight, free fatty acid, TC, LDL-c, and TG levels, and the renal lipid accumulations of HFD-fed mice were also significantly reduced (108). The bodyweight lowering and hypolipidemic effects of D. officinale (150 mg/kg) on obesity-induced HFD mice were investigated for 12 weeks. The results revealed a significant reduction in hepatic lipid accumulation through decreasing serum lipid levels (TG, TC, and LDL-C) and increasing HDL-C content. Furthermore, D. officinale improved the risk of obesity-associated abnormal lipid metabolism and insulin resistance by enhancing the expression of PPAR-γ, which acts as a potent therapeutic agent for obesity-associated lipid metabolism disorder and insulin resistance (107). The effect of D. officinale at a dose of 2.37 g/kg induced by an HFD in mice was investigated for 40 consecutive days. In this study, oral administration of D. officinale resulted in a reduction in carbohydrate energy, amino acid metabolism of intestinal mucosal flora, food intake, and body weight gain. Moreover, this extract showed better lipid-lowering properties in female mice than in male mice (109). To evaluate the anti-obesity and hypolipidemic effects of tin caulis Dendrobium polysaccharide, HFD rats were administered a dose of 500 mg/kg of this plant orally for 8 weeks. In this experiment, Dendrobium polysaccharide showed a significant improvement in fat tissue hypertrophy and excessive fatty deposition in the liver and also decreased food consumption and body weight (110). The hypolipidemic and bodyweight loss effects of a rich-polyphenols extract of D. loddigesii on diabetic mice were investigated. The present study demonstrated that D. loddigesii (100 mg/kg, for 8 weeks) significantly decreased body weight, blood glucose, and fatty liver in the mice. On the other hand, D. loddigesii exhibited a significant reduction in serum lipids (TG, TC, and LDL-C), while the status of anti-oxidant and HDL-C activity increased (68). These results are provided in response to the question of whether Dendrobium has protective effects on obesity via decreasing LDL-C, TC, FINS, and TG, and growing the HDL-C levels in the serum. Also, Dendrobium shows its anti-obesity effects by improving fat tissue hypertrophy and excessive fatty deposition in the liver. Thus, this plant is effective at decreasing symptoms of bodyweight and lipid-lowering, and it can be said with confidence (Table 5). Clinical studies Although several studies are investigating the protective effects of different species of Dendrobium, only a few clinical studies have been conducted. In a clinical study, 120 T2 DM patients received Dendrobium compound (2 g/day) for 90 days. In this study, Dendrobium demonstrated a potent antidiabetic effect on patients via decreasing the levels of fasting FBG, 2 hr postprandial blood glucose (2h BG), and insulin resistance (111). Additionally, the safety and effectiveness of D. huoshanense were determined with laboratory and clinical tests. Oral administration of the polysaccharide from D. huoshanense (2000-4000mg, 4 weeks) could significantly decrease cytokine levels associated with atopic dermatitis and show beneficial effects on symptoms. No serious adverse effects happened during all 4 weeks of treatment (112). Moreover, the oral effects of D. candidum extract (0.5 g/5 ml three times daily) were evaluated in female patients. According to the results, the mentioned dose was safe and promoted the expression of aquaporin-5 (AQP-5) in the labial glands of patients with Sjögren’s syndrome (113). In 2009, clinical research was designed to evaluate the safety of Runmushu Oral Liquid (RMS) in postmenopausal patients with xerophthalmia. In this study, RMS could show a therapeutic effect and alleviated significantly the eye symptoms in postmenopausal women xerophthalmia groups (114). Additionally, there is ongoing interventional research on the clinical effects of D. nobile Lindl., focusing on metabolic syndrome. In the mentioned study, the effective and safe dose range of D. nobile Lindl. was predicted at 12 g per day (twice a day, 6 g each time) (115). Safety In a study to evaluate the minimal lethal dose (LD10), the aqueous extract of D. moniliforme was administered orally (0, 2500, and 5000 mg/kg) in Sprague-Dawley (SD) rats. According to the previous findings, no adverse effects were observed after oral administration of D. moniliforme (5,000 mg/kg or less) in rats. An estimated LD10 is over 5,000 mg/kg/body weight (116). In another study, the genetic and oral toxicity of the aqueous extracts of D. taiseed Tosnobile (800, 1600, and 2400 mg/kg, 90 days) were investigated in SD rats. No clinical signs of mortality or toxicity were associated with D. taiseed Tosnobile administration at any doses during a 90-day sub-chronic investigation in animals (117). Different species of Dendrobium have been formulated as eye drops, tablets, and capsules. D. aurantiacum is reported to be safe, and no observable signs of toxicity were associated with D. aurantiacum eye drops in mice. Also, no irritation or irritability reactions have been reported after single-dose or multiple-dose administration of this plant in rabbits’ and guinea pigs’ eyes or skin (118). We comprehensively reviewed the protective effects of various species of Dendrobium, which are characterized by hypotensive, hypolipidemic, hypoglycemic, and anti-obesity effects in different experimental models. On the other hand, the protective effect of dendrofalconerol A, polyphenols, 3,4-dihydroxy-4′,5-dimethoxybibenzyl, moscatilin, lusianthridin, and dendrogibsol extracted from Dendrobium species was reviewed in detail. This study was limited by the absence of human studies for many suggested effects of Dendrobium species. Figure 1 The bioactive constituents of Dendrobium include gigantol, moscatilin, dendrofalconerol A, dendrochrysanene and denbonobin Table 1 Different species of Dendrobium and their bioactivities Ref Bioactivity Components Species name (37) Antioxidant, anti-diabetic activities Polysaccharides D. officinale (76) Neuronal protective, anti-diabetes, anti-hyperlipidemia Alkaloids D. nobile (112) Anti-inflammatory activity Polysaccharide D. huoshanense. (119) Inhibition of cataractogenesis, Anti-oxidant activity Bisbenzyl (gigantol) D. aurantiacum. (120) Anti-angiogenic activity Anti-platelet aggregation activity Bibenzyls (moscatilin) D. loddigesii (121) Antiplatelet aggregation activity Bibenzyl trigonopols A D. trigonopu s (122) Anti-inflammatory activity, Anti-oxidant Phenanthrenes (dendrochrysanene) D. chrysanthum (123) Anti-cancer Bisbenzyl (Dendrofalconerol A) D. falconer (124) Anti-platelet aggregation activity Dendroflorin) Fluorenones) D. densiflorum (30) Anti-inflammatory activity Phenanthrene D. denneanum (125) Cytotoxic, Antimigratory Bisbenzyl (gigantol, moscatilin) D. brymerianum (126) Anti-oxidant activity Polysaccharide D. denneanum Figure 2 Schematic mechanistic description of Dendrobium officinale effects on metabolic syndrome Table 2. Anti-diabetic effects of different species of Dendrobium Ref Mechanisms Results Dosage mg/kg/day) /Study model Active constituents/type of extract Species of Dendrobium In vivo studies (25) Increase the number of β-cells/ Regulate the insulin signaling pathway/ phosphatidylinositol 3kinase/protein kinase B (PI3K/AKT) action Normalize hyperglycemia 50 mg/kg/day and 200 mg/kg/day, 5 weeks/On to STZ-HFD induced diabetic mice Polysaccharides D. huoshanense (68) Antioxidant property ↓Blood glucose ↓Insulin resistance ↑ SOD, CAT, GSH 25, 50, 100 mg/kg, gavage, 8 weeks/On diabetic db/db mice Polyphenols D. loddigesii (37) Antioxidant ↓Blood glucose 20, 40, 80, and 160 mg/kg, 8 weeks/On T2DM rats Polysaccharides D. officinale (67) Cyclic adenosine monophosphate protein kinase A (cAMP-PKA) signaling pathway Ameliorate hyperglycemia and hepatic glucose metabolism Regulate liver-glycogen structure and glucagon-mediated signaling pathways Increase hepatic glycogen synthesis Suppressed hepatic gluconeogenesis and glycogen degradation 100, 200, and 400 mg/kg, 4 weeks/ On STZ-HFD induced diabetic mice Polysaccharides D. officinale (69) Activation of the PPAR-α/ c-Jun N-terminal kinase (JNK) pathway Decrease in phosphorylation of JNK increase in p-IRS1and E-cadherin, 75, 150, 300 mg/kg, i.p. 12 weeks/ On HFD/STZ-induced diabetic cardiomyopathy mice - D. officinale (71) Inhibition the expression of connective CTGF, VEGF and GLUT-1. Normalize hyperglycemia ↓Serum creatinine, ↓blood urea nitrogen ↓ urea 0.2, 0.4, and 0.8 g/kg/ On kidneys in diabetic rats - D. candidum (72) Reduce the expression transforming growth factor-β1 (TGF-β1)/Smads signal transduction pathway Anti-diabetic effects ↓FBG (12 g/kg for 8 weeks)/In db/db mice Not mentioned D. mixture (43) Toll-like receptors (TLRs)/ promote insulin secretion of pancreatic islet beta cells ↓FBG ↑FINS ↓insulin-resistant 5 and 10 ml/kg, for 4 weeks/ in diabetic rats induced by STZ Dried stems D. officinale Kimura et Migo (73) Blood glucose level Anti-diabetic effects 700 mg/kg for 2 weeks Aqueous extract D. officinale Kimura & Migo (75) — ↓Blood glucose ↓Glucose tolerance 100 and 200 mg/kg/ In adrenalin and alloxan-induced diabetic mice Polysaccharides D. moniliforme (67) Prevented β-cells apoptosis and decrease liver lipid accumulation Ameliorate diabetes symptoms 100 and 200 mg/kg, , 2 to 5 weeks/ In diabetic rats Extract D. fimbriatum (74) Activation of PI3K/ Akt ↓ FBG ↓GSP ↓ ALT ↓ AST Decrease G6Pase, PEPCK and FoxO1 17.2 g/kg/day,12 Weeks/ In diabetic rats Polysaccharides D. mixture (78) Inhibition the NF-𝜅B signaling pathway. Ameliorate diabetic retinopathy and retinal inflammation in diabetic condition 30 and 300 mg/kg, , 4 weeks/ In STZ-induced diabetic rats Extract D. chrysotoxum Lindl (29) Reduction significantly in blood glucose levels Hypoglycemic activity 200 and 500 mg/kg, orally for 1 week/ on alloxan-induced diabetic polysaccharide D. chrysotoxum In vitro studies (59) α-glucosidase inhibitory activity Hypoglycemic effects 200 µg/ml Dendrofalconerol A D. tortile Lindl (60) Inhibition of α-amylase, α-glucosidase, radical scavenging response. Hypoglycemic effects 3,4-dihydroxy-4′,5-dimethoxybibenzyl D. officinale (58) Increased glucose uptake Reduce the raised level of insulin resistance in 3T3-L1 cells Anti-diabetic effect 1.02, 2.03, 4.06, 8.12, and 16.25 µg/ml)/3T3-L1 cells Shihunine-rich extract D. loddigesii (63) Regulate the PI3K/AKT signaling pathway Ameliorate glucose metabolism 100, 200 and 400 μg/ml/ HepG2 cells Polysaccharides D. officinale (64) Induce GLP-1 secretion in STC-1 cells Hypoglycemic activity 0, 0.2, 2, 20, 200, and 2000 μg/ml/ STC-1 cells Polysaccharides D. officinale (65) Inhibition of both α-glucosidase and pancreatic lipase enzymes Reduce hyperglycemia 100 µg/ml/ L6 myotubes cells 1 µg/ml/ L6 myotubes cells 50µg/ml Moscatilin Lusianthridin Methoxy-7-hydroxy-9,10-dihydro-1,4-phenanthrenequinone D. formosum Roxb. ex Lindl (66) α glucosidase inhibitory activity Hypoglycemic activity 100 µg/ml Dendrogibsol D. gibsonii (29) Anti-oxidant Anti-oxidant and hypoglycemic effects Mouse splenocytes and jurkat cells Polysaccharides D. chrysotoxum Lindl STZ: Streptozotocin; HFD: high-fat diet; SOD: superoxide dismutase; CAT: catalase; GSH: glutathione peroxidase; TC: total cholesterol; TG: triglyceride; HDL C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; FBG: fasting blood glucose; GSP: glycated serum proteins; ALT: alanine aminotransaminase; AST: aspartate aminotransferase; G6Pase: glucose 6-phosphatase; CTGF: connective tissue growth factor; VEGF: vascular endothelial growth factor; GLUT-1: Glucose transporter1; PEPCK: phosphoenolpyruvate carboxykinase 1; forkhead box O1; NF-𝜅B: nuclear factor-κB; GLP-1: Glucagon-like peptide-1; 2hBG: 2 hr postprandial blood glucose Table 3 Hypolipidemic effects of different species of Dendrobium Ref Mechanisms Results Dosage mg/kg/day) /Study model Active constituents/ type of extract Species of Dendrobium In vivo studies (69) Activation expression of PPAR-α and decrease in expression of p-JNK proteins Increase fatty acid metabolism ↓ TC ↓ TG ↓LDL-C ↓ FINS ↑ HDL-c 75, 150, 300 mg/kg, for12 weeks/ In diabetic and high fat diet rats Polysaccharides D. officinale (87) Reduce the levels of hepatic lipids, including TC, TG, TAGs, AST, ALT and FFA Ameliorate liver lipid metabolism in NAFLD model Reduction in FA synthesis, uptake, and desaturation and promote FA β-oxidation. 0.6 g/kg per day for 3 weeks/ In a mouse model of progressive NAFLD with the HSHF diet Polyphenols D. officinale (88) Antioxidant and lipid-lowering effects Anti-hyperlipidemic effect ↓ lipid profile ↓ LDL-C ↓ TC ↓ TG ↓ ALT, AST ↑ HDL-c 0.25g/kg, 0.5g/kg, or 1g/kg/ In hyperlipidemic rats Polysaccharides D. officinale (90) Inhibition plaque formation by decreasing lipid accumulation ↓ HCD ↓ TC ↓ TG ↓ MDA ↓ ROS In the blood vessels at the atherosclerosis zebrafish Polysaccharides D. huoshanense (90) Antioxidant and hypocholesterolemic activity ↓ LDL-C ↓ VLDL-C ↓ TG, TC ↓ AST, ALT ↑ HDL-c ↑ ADH, ALDH ↑ SOD , GSH-Px 30 days/ On sub-acute alcohol induced liver injury in mice Water extract, alcohol-soluble extract, alcohol-insoluble extract and crude extract D huoshanense (76) Activation of Acox1 and Cpt1a genes Up regulate The adipose tissue triglyceride lipase (ATGL/Pnpla2) Decrease the expression of Srebp1 Reduce hyperlipidemia 10–80 mg/kg, for 8 days/ in HFD mice Alkaloids D. nobile Lindl. alkaloids (68) Lipid-lowering effect ↓ LDL-C ↓ TC ↓ TG ↑ HDL-c 25, 50,100 mg/kg for 8 weeks/ in diabetic mice rich-polyphenols D. loddigesii (40) - Decrease in lipid accumulation, maintains lipid metabolism NLRP3 inflammasome activation 200 or 400 mg/kg , 6 week/ on HFD diet mice Active constituents D. candidum Wall. ex Lindl (74) Lipid-lowering effect ↓ LDL-C ↓ VLDL-C ↓ TG ↓ ALT ↑ HDL-c 17.2 g/kg/day,12 Weeks/ on HFD and highsugar diet rats Polysaccharides D. mixture In vitro studies (58) elevate the expression levels of GLUT-4 and p-AMPK in the adipose tissue Increase the expression levels of PPAR_ and p-AMPK in the liver tissue Lipid-lowering effect Decrease the intracellular accumulation of fat droplets and TG Promote the 2-NBDG uptake 03, 4.06, 8.12, and 16.25 µg/ml/3T3-L1 cells - D. loddigesii l (86) Increase in free radical scavenging activity factors (SOD, CAT, GPx, GSH) Inhibition effect on the FeCl2-induced lipid peroxidation 0.5, 0.1, 1.5 and 2.0 mg/ml Polysaccharides D. huoshanense TC: total cholesterol; TG: triglyceride; HDL C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; FINS: fasting insulin; ALT: alanine amino transaminase; AST: aspartate aminotransferase; NAFLD: non-alcoholic fatty liver disease; TAG: Triacylglycerol; FFA: free Fatty Acids; HCD: high-cholesterol diet; ROS: reactive oxygen species; VLDL-C: very low-density lipoprotein cholesterol; ALDH: aldehyde dehydrogenase; GLUT-4: glucose transporter 4; AMPK: AMP-activated protein kinase; SOD: superoxide dismutase; GPx: glutathione peroxidase Table 4 Hypotensive effects of different species of Dendrobium Ref Mechanisms Results Dosage mg/kg/day) /Study model Active constituents/ type of extract Species of Dendrobium In vivo studies (98) Activation of PI3K/AKT/eNOS signaling pathways ↑NO generation inhibition ICAM-1 and ET-1 Anti-hypertensive activity Reduce hypertension and vascular dysfunction in a hypertensive model 1.65, 3.30, 5.00 g·kg,4 weeks/ on hypertensive SD rats fed with high-sugar, high-fat diet and alcohol - compound Dendrobium (45) Reduction in plasma content of ET-1, TXB₂ and thickening of the thoracic aorta increase the levels PGI₂, NO and the activities of vascular endothelial cells Normalized systolic blood pressure, mean arterial pressure and improved vascular diastolic dysfunction 3, 1 g kg⁻¹ , 6 weeks/ hypertensive rats induced by high glucose and high fat - D. officinale (100) Decrease blood pressure (systolic blood pressure, diastolic blood pressure and mean blood pressure Improve hypertension 32 weeks/ hypertensive rats induced by long-term-alcohol - D. officinale (99) Decrease systolic blood pressure and lipid profile alleviate hypertension and metabolic disorders in metabolic hypertension 4 weeks/ on metabolic hypertensive rats induced by high-sugar, high-fat diet and alcohol -Ethanol extract D. officinale granule (97) Inhibition of the ERK signaling Alleviate heart function and cardiac hypertrophy Reduce LVSP HW/BW, LV/TL and ANP 0.13 and 0.78 g/kg, 4 weeks/ isoproterenol-induced cardiac hypertrophy model - D. candidum In vitro studies (97) Inhibition of the ERK signaling Improves cardiac hypertrophy Reduce the up-regulated mRNA levels ANP 2 mg/ml/ rat cardiac myocyte H9c2 cells - D. candidum NO: nitric oxide; ICAM-1: intercellular adhesion molecule1; ET-1: endothelin 1; TXB₂: thromboxane B₂; PGI₂: prostacyclin; ERK: extracellular-signal-regulated kinase; LVSP: left ventricular systolic pressure; HW/BW: heart to-body weight ratio; LV/TL: left ventricular/tibia length; ANP: atrial natriuretic peptide Table 5 Anti-obesity effects of different species of Dendrobium Ref Mechanisms Results Dosage mg/kg/day) /Study model Active constituents/ Species of Dendrobium In vivo studies (108) lipid-lowering effect Lipid-lowering effect in HFD-induced obesity Decrease body weight ↓TC ↓ LDL -c, TG Decrease free fatty acid level and renal lipid accumulations 200 mg/kg, 9 weeks/ High fat diet mice Methanolic extract D. moniliforme (107) ↓TC ↓ LDL -c, TG ↑HDL Up-regulate the expression of PPAR-γ Decrease in liver lipid accumulation Improve obesity-associated abnormal lipid metabolism and insulin resistance 150 mg/kg, 12 weeks/ on obesity-induced HFD mice Polysaccharide D. officinale (109) - Reduction in the carbohydrate energy, amino acid metabolism of intestinal mucosal flora, food intake and the bodyweight gain lipid lowering effect 2.37 g·kg−1, 40 days/High fat diet rats· Not mentioned D. officinale (76) Improve in fat tissue hypertrophy and excessive fatty deposition in the liver Decrease in food consumption and body weight 500 mg/kg,8 weeks/ High fat diet mice· Polysaccharide D.tin caulis (68) - Decrease body weight, improve the fatty liver ↓TC ↓ LDL -c, TG ↑HDL-C, antioxidant status 100 mg/kg , 8 weeks/Male obese diabetic mice polyphenols D. loddigesii In vitro studies (107) Up-regulate the expression of PPAR-γ in adipocytes, myocytes, and hepatocytes Promote the insulin-stimulated glucose uptake of 3T3-L1 adipocytes and C2C12 myocytes, while the glucose output of hepatocytes decreased. 200 μg/ml for 48h/3T3-L1 adipocytes, C2CL2 myocytes, and hepatocytes Polysaccharide D. Officinale HFD: high fat diet; TC: total cholesterol; TG: triglyceride; HDL C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TC: total cholesterol; TG: triglyceride; NO: nitric oxide; PGI2: prostacyclin Conclusion In this review, our team summarized different in vitro, in vivo, and clinical studies to find out the role of different species of Dendrobium and their active constituents on MetS which is known as a global health challenge. According to the experimental studies reported in the literature, the different species of Dendrobium can be good candidates for managing MetS complications, including diabetes, hypertension, dyslipidemia, and obesity. These plants regulate dyslipidemia by reducing the levels of LDL-C, TG, and TC and elevating the levels of HDL-C in the blood by various mechanisms, such as anti-oxidant activity, and up-regulating the expression of PPAR-γ and p-AMPK in the liver tissue. Dendrobium also decreases hypertension via activating PI3K/AKT/eNOS signaling pathways, NO generation, and inhibition of ICAM-1 and ET-1. Furthermore, the hypoglycemic effects of species of Dendrobium can be mediated by various mechanisms, such as increasing the number of β-cells, regulating the insulin signaling pathway, and PI3K/AKT action. Despite the promising findings of several in vitro and in vivo studies, the lack of human studies about the safety and efficacy of Dendrobium is obvious. Hence, further clinical research projects are needed to confirm the effectiveness and safety of these plants as candidates for the treatment of MetS in humans. Authors’ Contributions HH Study conception, design and supervision of the research; MGR Critical revision of the paper, supervision of the research; ZO Preparation of original draft. All authors have agreed to the contents and approved the final version for publication Funding This review received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Conflicts of Interest The authors declare that they have no conflicts of interest. Acknowledgment The authors are thankful to Mashhad University of Medical Sciences (MUMS), Mashhad, Iran. ==== Refs References 1 Rodriguez-Correa E Gonzalez-Perez I Clavel-Perez PI Contreras-Vargas Y Carvajal K Biochemical and nutritional overview of diet-induced metabolic syndrome models in rats: What is the best choice? Nutr Diabetes 2020 10 24 32616730 2 Saklayen MG The global epidemic of the metabolic syndrome Curr Hypertens Rep 2018 20 12 29480368 3 Katsimardou A Imprialos K Stavropoulos K Sachinidis A Doumas M Athyros V Hypertension in metabolic syndrome: Novel insights Curr Hypertens Rev 2020 16 12 18 30987573 4 Charlton M Obesity, hyperlipidemia, and metabolic syndrome Liver Transplant 2009 15 83 89 5 Mansyur MA Bakri S Patellongi IJ Rahman IA The association between metabolic syndrome components, low-grade systemic inflammation and insulin resistance in non-diabetic Indonesian adolescent male Clin Nutr ESPEN 2020 35 69 74 31987123 6 Bullon-Vela V Abete I Tur JA Pinto X Corbella E Martinez-Gonzalez MA Influence of lifestyle factors and staple foods from the mediterranean diet on non-alcoholic fatty liver disease among older individuals with metabolic syndrome features Nutrition 2020 71 110620 31838461 7 Kawamoto R Tabara Y Kohara K Miki T Kusunoki T Takayama S Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults Lipids Health Dis 2011 10 79 8 Wagner K-H Schwingshackl L Draxler A Franzke B Impact of dietary and lifestyle interventions in elderly or people diagnosed with diabetes, metabolic disorders, cardiovascular disease, cancer and micronutrient deficiency on micronuclei frequency–a systematic review and meta-analysis Mutat Res 2021 787 108 367 9 Razavi BM Hosseinzadeh H A review of the effects of Nigella sativa L and its constituent, thymoquinone, in metabolic syndrome J Endocrinol Invest 2014 37 1031 1040 25125023 10 Razavi BM Lookian F Hosseinzadeh H Protective effects of green tea on olanzapine-induced-metabolic syndrome in rats Biomed Pharmacother 2017 92 726 731 28586744 11 Tajmohammadi A Razavi BM Hosseinzadeh H Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review Phytother Res 2018 32 1933 1949 30015401 12 Tabeshpour J Razavi BM Hosseinzadeh H Effects of avocado (Persea americana) on metabolic syndrome: A comprehensive systematic review Phytother Res 2017 31 819 837 28393409 13 Razavi BM Hosseinzadeh H Saffron: a promising natural medicine in the treatment of metabolic syndrome J Sci Food Agric 2017 97 1679 1685 27861946 14 Tousian Shandiz H Razavi BM Hosseinzadeh H Review of Garcinia mangostana and its xanthones in metabolic syndrome and related complications Phytother Res 2017 31 1173 1182 28656594 15 Sanati S Razavi BM Hosseinzadeh H A review of the effects of Capsicum annuum L and its constituent, capsaicin, in metabolic syndrome Iran J Basic Med Sci 2018 21 439 448 29922422 16 Akaberi M Hosseinzadeh H Grapes (Vitis vinifera) as a potential candidate for the therapy of the metabolic syndrome Phytother Res 2016 30 540 556 26800498 17 Tabeshpour J Imenshahidi M Hosseinzadeh H A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome Iran J Basic Med Sci 2017 20 557 568 28656091 18 Hosseinzadeh H Nassiri-Asl M Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid J Endocrinol Invest 2014 37 783 788 24879037 19 Yarmohammadi F Ghasemzadeh Rahbardar M Hosseinzadeh H Effect of eggplant (Solanum melongena) on the metabolic syndrome: A review Iran J Basic Med Sci 2021 24 420 427 34094022 20 Cardoso JC Zanello CA Chen JT An oerview of Orchid protocorm-like bodies: Mass propagation, biotechnology, molecular aspects, and breeding Int J Mol Sci 2020 21 985 21 Cakova V Bonte F Lobstein A Dendrobium: sources of active ingredients to treat age-related pathologies Aging Dis 2017 8 827 849 29344419 22 Xiaohua J Singchi C Yibo L Taxonomic revision of Dendrobium moniliforme complex (Orchidaceae) Sci Hortic 2009 120 143 145 23 De L Rao A Rajeeva P Srivastava M Morphological characterization in Dendrobium species Int J Biosci 2015 4 1198 1215 24 Zuo J Zu M Liu L Song X Yuan Y Composition and diversity of bacterial communities in the rhizosphere of the Chinese medicinal herb Dendrobium BMC Plant Biol 2021 21 127 33663379 25 Wang HY Li QM Yu NJ Chen WD Zha XQ Wu DL Dendrobium huoshanense polysaccharide regulates hepatic glucose homeostasis and pancreatic beta-cell function in type 2 diabetic mice Carbohydr Polym 2019 211 39 48 30824102 26 Li TM Deng MZ Effect of dendrobium mixture on hypoglycemic and the apoptosis of islet in rats with type 2 diabetic mellitus Zhongyaocai 2012 35 765 769 23213742 27 Xu J Han Q-B Li S-L Chen X-J Wang X-N Zhao Z-Z Chemistry, bioactivity and quality control of Dendrobium, a commonly used tonic herb in traditional Chinese medicine Phytochem Rev 2013 12 341 367 28 Ng TB Liu J Wong JH Ye X Wing Sze SC Tong Y Review of research on Dendrobium, a prized folk medicine Appl Microbiol Biotechnol 2012 93 1795 1803 22322870 29 Zhao Y Son YO Kim SS Jang YS Lee JC Anti-oxidant and anti-hyperglycemic activity of polysaccharide isolated from Dendrobium chrysotoxum Lindl Int J Biochem Mol Biol 2007 40 670 677 30 Lin Y Wang F Yang LJ Chun Z Bao JK Zhang GL Anti-inflammatory phenanthrene derivatives from stems of Dendrobium denneanum Phytochemistry 2013 95 242 251 24042064 31 Gu FL Huang RS He XM Chen NF Han BX Deng H Dendrobium huoshanense polysaccharides prevent inflammatory response of ulcerative colitis rat through inhibiting the NF-kappaB signaling pathway Chem Biodivers 2021 18 e2100130 34080308 32 Sattayasai N Sudmoon R Nuchadomrong S Chaveerach A Kuehnle AR Mudalige-Jayawickrama RG Dendrobium findleyanum agglutinin: production, localization, anti-fungal activity and gene characterization Plant Cell Rep 2009 28 1243 1252 19495769 33 Xing Y-M Chen J Cui J-L Chen X-M Guo S-X Antimicrobial activity and biodiversity of endophytic fungi in Dendrobium devonianum and Dendrobium thyrsiflorum from Vietman Curr Microbiol 2011 62 1218 1224 21181405 34 Luo A Fan Y In vitro anti-oxidant of a water-soluble polysaccharide from Dendrobium fimhriatum Hook var.oculatum Hook. Int J Mol Sci 2011 12 4068 4079 21747725 35 Paudel MR Joshi PR Chand K Sah AK Acharya S Pant B Anti-oxidant, anticancer and antimicrobial effects of In vitro developed protocorms of Dendrobium longicornu Biotechnol Rep 2020 28 e00527 36 Liu H Ye H Sun C Xi H Ma J Lai F Anti-oxidant activity in HepG2 cells, immunomodulatory effects in RAW 264 7 cells and absorption characteristics in Caco-2 cells of the peptide fraction isolated from Dendrobium aphyllum Int J Food Sci Technol 2018 53 2027 2036 37 Yang J Chen H Nie Q Huang X Nie S Dendrobium officinale polysaccharide ameliorates the liver metabolism disorders of type II diabetic rats Int J Biol Macromol 2020 164 1939 1948 32763406 38 Guo M Li B Wang R Liu P Chen Q Occurrence of dieback disease caused by Fusarium equiseti on Dendrobium officinale in China Crop Prot 2020 137 105209 39 Tian CC Zha XQ Luo JP A polysaccharide from Dendrobium huoshanense prevents hepatic inflammatory response caused by carbon tetrachloride Biotechnol Biotechnol Equip 2015 29 132 138 26019626 40 Yin XZ Chi WM Zhang L Su YQ Zhang ZY Xue CB Protective effects of Dendrobium candidum Wall ex Lind on high-fat diet-induced liver damage in mice J Food Biochem 2021 45 e13687 33665859 41 Fang J Lin Y Xie H Farag MA Feng S Li J Dendrobium officinale leaf polysaccharides ameliorated hyperglycemia and promoted gut bacterial associated SCFAs to alleviate type 2 diabetes in adult mice Food Chem: X 2022 13 100207 35498995 42 Peng D Tian W An M Chen Y Zeng W Zhu S Characterization of antidiabetic effects of Dendrobium officinale derivatives in a mouse model of type 2 diabetes mellitus Food Chem 2023 399 133974 35998493 43 Zhao M Han J Dendrobium Officinale Kimura et Migo ameliorates insulin resistance in rats with diabetic nephropathy Med Sci Monit Basic Res 2018 24 84 92 29849017 44 Zhang S Tu H Zhu J Liang A Huo P Shan K Dendrobium nobile Lindl polysaccharides improve follicular development in PCOS rats Int J Biol Macromol 2020 149 826 834 31978473 45 Liang KL Fang P Shi QQ Su J Li B Chen SH Antihypertensive effect and mechanism of Dendrobium officinale flos on high-blood pressure rats induced by high glucose and high fat compound alcohol Zhongguo Zhong Yao Za Zhi 2018 43 147 153 29552825 46 Li B Wang H-Y Huang J-H Xu W-F Feng X-J Xiong Z-P Polysaccharide, the active component of Dendrobium officinale, ameliorates metabolic hypertension in rats via regulating intestinal flora-SCFAs-vascular axis Front Pharmacol 2022 13 935714 35899110 47 Chen P Wu Q Feng J Yan L Sun Y Liu S Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis Signal Transduct Target Ther 2020 5 51 32382060 48 Zhang K Zhou X Wang J Zhou Y Qi W Chen H Dendrobium officinale polysaccharide triggers mitochondrial disorder to induce colon cancer cell death via ROS-AMPK-autophagy pathway Carbohydr Polym 2021 264 118018 33910741 49 American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 2014 37 81 90 23959568 50 Ormazabal V Nair S Elfeky O Aguayo C Salomon C Zuniga FA Association between insulin resistance and the development of cardiovascular disease Cardiovasc Diabetol 2018 17 122 30170598 51 Reaven GM Role of insulin resistance in human disease (syndrome X): an expanded definition Annu Rev Med 1993 44 121 131 8476236 52 Chandy A Pawar B John M Isaac R Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications Saudi J Kidney Dis Transpl 2008 19 924 928 18974577 53 Kar P Holt RI The effect of sulphonylureas on the microvascular and macrovascular complications of diabetes Cardiovasc Drugs Ther 2008 22 207 213 18288596 54 Vazquez-Prieto MA Bettaieb A Haj FG Fraga CG Oteiza PI (-)-Epicatechin prevents TNFalpha-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes Arch Biochem Biophys 2012 527 113 118 22425757 55 Bischoff Bayer H Pharmacology of α-glucosidase inhibition Eur J Clin Invest 1994 24 3 10 56 Yang H Yang L Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy J Mol Endocrinol 2016 57 93 108 57 Bragt MC Popeijus HE Peroxisome proliferator-activated receptors and the metabolic syndrome Physiol Behav 2008 94 187 197 18191967 58 Rasalam R Barlow J Kennedy M Phillips P Wright A GLP-1 Receptor agonists for type 2 diabetes and their role in primary care: An Australian perspective Diabetes Ther 2019 10 1205 1217 31183762 59 Limpanit R Chuanasa T Likhitwitayawuid K Jongbunprasert V Sritularak B a-Glucosidase inhibitors from Dendrobium tortile Rec Nat Prod 2016 10 609 616 60 Chu C Li T Pedersen HA Kongstad KT Yan J Staerk D Antidiabetic constituents of Dendrobium officinale as determined by high-resolution profiling of radical scavenging and α-glucosidase and α-amylase inhibition combined with HPLC-PDA-HRMS-SPE-NMR analysis Phytochem Lett 2019 31 47 52 61 Li XW Huang M Lo K Chen WL He YY Xu Y Anti-diabetic effect of a shihunine-rich extract of Dendrobium loddigesii on 3T3-L1 cells and db/db mice by up-regulating AMPK-GLUT4-PPARα Molecules 2019 24 2673 62 Sun J Zhang F Yang M Zhang J Chen L Zhan R Isolation of alpha-glucosidase inhibitors including a new flavonol glycoside from Dendrobium devonianum Nat Prod Res 2014 28 1900 1905 25189122 63 Wang K Wang H Liu Y Shui W Wang J Cao P Dendrobium officinale polysaccharide attenuates type 2 diabetes mellitus via the regulation of PI3K/Akt-mediated glycogen synthesis and glucose metabolism J Funct Foods 2018 40 261 271 64 Kuang MT Li JY Yang XB Yang L Xu JY Yan S Structural characterization and hypoglycemic effect via stimulating glucagon-like peptide-1 secretion of two polysaccharides from Dendrobium officinale Carbohydr Polym 2020 241 116326 65 Inthongkaew P Chatsumpun N Supasuteekul C Kitisripanya T Putalun W Likhitwitayawuid K α-glucosidase and pancreatic lipase inhibitory activities and glucose uptake stimulatory effect of phenolic compounds from Dendrobium formosum Rev Bras Farmacogn 2017 27 480 487 66 Thant MT Chatsumpun N Mekboonsonglarp W Sritularak B Likhitwitayawuid K New fluorene derivatives from Dendrobium gibsonii and their alpha-glucosidase inhibitory activity Molecules 2020 25 4931 67 Liu Y Yang L Zhang Y Liu X Wu Z Gilbert RG Dendrobium officinale polysaccharide ameliorates diabetic hepatic glucose metabolism via glucagon-mediated signaling pathways and modifying liver-glycogen structure J Ethnopharmacol 2020 248 112308 68 Li XW Chen HP He YY Chen WL Chen JW Gao L Effects of rich-polyphenols extract of Dendrobium loddigesii on anti-diabetic, anti-inflammatory, anti-oxidant, and gut microbiota modulation in db/db mice Molecules 2018 23 m2 20 69 Zeng J Li D Li Z Zhang J Zhao X Dendrobium officinale attenuates myocardial fibrosis via inhibiting EMT signaling pathway in HFD/STZ-induced diabetic mice Biol Pharm Bull 2020 43 864 872 32378562 70 Altamimi TR Gao S Karwi QG Fukushima A Rawat S Wagg CS Adropin regulates cardiac energy metabolism and improves cardiac function and efficiency Metabolism 2019 98 37 48 31202835 71 Chang J Zhou Y Cong G Guo H Guo Y Lu K Dendrobium candidum protects against diabetic kidney lesions through regulating vascular endothelial growth factor, glucose tansporter 1, and connective tissue growth factor expression in rats J Cell Biochem 2019 120 13924 13931 31021475 72 Chen Y Lin X Zheng Y Yu W Lin F Zhang J Dendrobium mixture improved diabetic nephropathy in db/db mice by regulating TGF-β1/smads signal transduction Evid Based Complement Alternat Med 2021 2021 9931983 73 Zheng H Pan L Xu P Zhu J Wang R Zhu W An NMR-based metabolomic approach to unravel the preventive effect of water-soluble extract from Dendrobium officinale Kimura & Migo on streptozotocin-induced diabetes in mice Molecules 2017 22 1543 74 Lin X Shi H Cui Y Wang X Zhang J Yu W Dendrobium mixture regulates hepatic gluconeogenesis in diabetic rats via the phosphoinositide-3-kinase/protein kinase B signaling pathway Exp Ther Med 2018 16 204 212 29896241 75 Yunlong C Guoqing H Ming Z Huijun L Hypoglycemic effect of the polysaccharide from Dendrobium moniliforme (L ) Sw J Zhejiang Univ Sci B 2003 30 693 696 76 Xu YY Xu YS Wang Y Wu Q Lu YF Liu J Dendrobium nobile Lind alkaloids regulate metabolism gene expression in livers of mice J Pharm Pharmacol 2017 69 1409 1417 28722145 77 Zhang Q Li J Luo M Xie GY Zeng W Wu Y Systematic transcriptome and regulatory network analyses reveal the hypoglycemic mechanism of Dendrobium fimbriatum Mol Ther Nucleic Acids 2020 19 1 14 31790971 78 Yu Z Gong C Lu B Yang L Sheng Y Ji L Dendrobium chrysotoxum Lindl alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decrease J Diabetes Res 2015 2015 518317 25685822 79 Luo J-P Deng Y-Y Zha X-Q Mechanism of polysaccharides from Dendrobium huoshanense on streptozotocin-induced diabetic cataract Pharm Biol 2008 46 243 249 80 Pan LH Li XF Wang MN Zha XQ Yang XF Liu ZJ Comparison of hypoglycemic and antioxidative effects of polysaccharides from four different Dendrobium species Int J Biol Macromol 2014 64 420 427 24370475 81 Hill MF Bordoni B Hyperlipidemia StatPearls [Internet]. Treasure Island (FL) 2022 Available from: https://www.ncbi.nlm.nih.gov/books/NBK559182 82 Ruotolo G Howard BV Dyslipidemia of the metabolic syndrome Curr Cardiol Rep 2002 4 494 500 12379172 83 Ye G Gao H Lin Y Ding D Liao X Zhang H Peroxisome proliferator-activated receptor A/G reprogrammes metabolism associated with lipid accumulation in macrophages Metabolomics 2019 15 36 84 Vernia S Cavanagh-Kyros J Garcia-Haro L Sabio G Barrett T Jung DY The PPARalpha-FGF21 hormone axis contributes to metabolic regulation by the hepatic JNK signaling pathway Cell Metab 2014 20 512 525 25043817 85 McIntosh AL Atshaves BP Landrock D Landrock KK Martin GG Storey SM Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female mice Lipids 2013 48 435 448 23539345 86 Tian CC Zha XQ Pan LH Luo JP Structural characterization and anti-oxidant activity of a low-molecular polysaccharide from Dendrobium huoshanense Fitoterapia 2013 91 247 255 24096144 87 Lei SS Zhang NY Zhou FC He X Wang HY Li LZ Dendrobium officinale regulates fatty acid metabolism to ameliorate liver lipid accumulation in NAFLD mice Evid Based Complement Alternat Med 2021 19 6689727 88 Zhao M Han J Dose-dependent effect of aqueous extract from Dendrobium officinale on blood lipids and lipid peroxidation in hyperlipidemic rats Pak J Pharm Sci 2020 33 929 935 33191215 89 Fan X Han J Zhu L Chen Z Li J Gu Y Protective activities of Dendrobium huoshanense C Z Tang et S J Cheng Polysaccharide against high-cholesterol diet-induced atherosclerosis in zebrafish Oxidative Med Cell Longev 2020 8365056 90 Meng H Wang H Zha X Pan L Luo J Comparison of hepatoprotective effects of different extracts from Dendrobium huoshanense against alcohol-induced subacute liver injury in mice J Food Sci 2015 36 229 234 91 Su TC Jeng JS Chien KL Sung FC Hsu HC Lee YT Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan Stroke 2001 32 2265 2271 11588311 92 Johansson BB Hypertension mechanisms causing stroke Clin Exp Pharmacol Physiol 1999 26 563 565 10405790 93 Rakugi H Yu H Kamitani A Nakamura Y Ohishi M Kamide K Links between hypertension and myocardial infarction Am Heart J 1996 132 213 221 8677859 94 Oparil S Acelajado MC Bakris GL Berlowitz DR Cifkova R Dominiczak AF Hypertension Nat Rev Dis Primers 2018 4 18014 95 Tham YK Bernardo BC Ooi JY Weeks KL McMullen JR Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets Arch Toxicol 2015 89 1401 1438 25708889 96 Tabassum N Ahmad F Role of natural herbs in the treatment of hypertension Pharmacogn Rev 2011 5 30 40 22096316 97 Cao YY Li K Li Y Tian XT Ba HX Wang A Dendrobium candidum aqueous extract attenuates isoproterenol-induced cardiac hypertrophy through the ERK signalling pathway Pharm Biol 2020 58 176 183 33826488 98 Yin C Xu YY Chen GY Li B He M Shi QQ Efficacy of compound Dendrobium on PI3K/AKT/eNOS signaling pathway in hypertensive rats induced by “dietary disorders’’ Zhongguo Zhong Yao Za Zhi 2018 43 2345 2351 29945389 99 Yan MQ Su J Yu JJ Yang ZY Wang T Chen SH Effects and active substances of ethanol extract from Dendrobium officinale on metabolic hypertensive rats induced by comprehensive dietary Zhongguo Zhong Yao Za Zhi 2019 44 4896 4904 31872598 100 Lv GY Xia CQ Chen SH Su J Liu XP Li B Effect of Dendrobium officinale granule on long-term-alcohol-induced hypertension rats Zhongguo Zhong Yao Za Zhi 2013 38 3560 3565 24490573 101 Li B He X Jin HY Wang HY Zhou FC Zhang NY Beneficial effects of Dendrobium officinale on metabolic hypertensive rats by triggering the enteric-origin SCFA-GPCR43/41 pathway Food Funct 2021 12 5524 5538 34002173 102 Fruhbeck G Toplak H Woodward E Yumuk V Maislos M Oppert JM Obesity: the gateway to ill health - an EASO position statement on a rising public health, clinical and scientific challenge in Europe Obes Facts 2013 6 117 120 23548858 103 Kojta I Chacinska M Blachnio-Zabielska A Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance Nutrients 2020 12 1305 104 Frasca D Blomberg BB Paganelli R Aging, obesity, and inflammatory age-related diseases Front immunol 2017 8 1745 29270179 105 Jung UJ Choi MS Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease Int J Mol Sci 2014 15 6184 6223 24733068 106 Leonardini A Laviola L Perrini S Natalicchio A Giorgino F Cross-Talk between PPARgamma and insulin signaling and modulation of insulin sensitivity PPAR Research 2009 2009 818945 20182551 107 Qu J Tan S Xie X Wu W Zhu H Li H Dendrobium officinale polysaccharide attenuates insulin resistance and abnormal lipid metabolism in obese mice Front Pharmacol 2021 12 659626 34194325 108 Lee W Eom DW Jung Y Yamabe N Lee S Jeon Y Dendrobium moniliforme attenuates high-fat diet-induced renal damage in mice through the regulation of lipid-induced oxidative stress Am J Chinese Med 2012 40 1217 1228 109 Li X Peng X Guo K Tan Z Bacterial diversity in intestinal mucosa of mice fed with Dendrobium officinale and high-fat diet Biotechnol J 2021 11 22 110 Xu D Zhang H Wang X Effects of tin caulis dendrobium polysaccharide on the prevention of non-alcoholic fatty liver disease in rats Rev Bras de Zootec 2017 46 652 656 111 Zhang J Zhang X Hong J Dendrobium compound in treating 90 cases of type 2 diabetes mellitus World J Tradit Chin Med 2011 610 6 112 Wu KG Li TH Chen CJ Cheng HI Wang TY A pilot study evaluating the clinical and immunomodulatory effects of an orally administered extract of Dendrobium huoshanense in children with moderate to severe recalcitrant atopic dermatitis Int J Immunopathol Pharmacol 2011 24 367 375 21658311 113 Xiao L Ng TB Feng YB Yao T Wong JH Yao RM Dendrobium candidum extract increases the expression of aquaporin-5 in labial glands from patients with Sjögren’s syndrome Phytomedicine 2011 18 194 198 20655712 114 Wei D Li YH Zhou WY Observation on therapeutic effect of runmushu oral liquid in treating xerophthalmia in postmenopausal women Zhongguo Zhong Xi Yi Jie He Za Zhi 2009 29 646 649 19852302 115 Zhang X Wang M Zhang C Liu Z Zhou S Clinical study of Dendrobium nobile Lindl intervention on patients with metabolic syndrome Medicine (Baltimore) 2021 100 e24574 33761635 116 Lee MJ Jung HK Kim MS Jang JH Sim MO Kim TM Acute toxicity and cytotoxicity evaluation of Dendrobium moniliforme aqueous extract in vivo and in vitro Lab Anim Res 2016 32 144 150 27729930 117 Yang LC Liao JW Wen CL Lin WC Subchronic and genetic safety assessment of a new medicinal Dendrobium species: Dendrobium taiseed Tosnobile in rats Evid Based Complement Alternat Med 2018 2018 8950534 29541145 118 Yi YQ Yang QH Su JF Chen J Qi H Chen D Experimental study on preclinical quality control, urgent poison and irritation of Dendrobium aurantiacum eye drops, a class I new drug against diabetic cataract Zhongguo Zhong Yao Za Zhi 2013 38 1061 1066 23847958 119 Fang H Hu X Wang M Wan W Yang Q Sun X Anti-osmotic and anti-oxidant activities of gigantol from Dendrobium aurantiacum va denneanum against cataractogenesis in galactosemic rats J Ethnopharmacol 2015 172 238 246 26119284 120 Gong CY Lu B Yang L Wang L Ji LL Bibenzyl from dendrobium inhibits angiogenesis and its underlying mechanism Yao Xue Xue Bao 2013 48 337 342 23724644 121 Hu JM Chen JJ Yu H Zhao YX Zhou J Two novel bibenzyls from Dendrobium trigonopus J Asian Nat Prod Res 2008 10 653 657 18636377 122 Yang L Qin LH Bligh SW Bashall A Zhang CF Zhang M A new phenanthrene with a spirolactone from Dendrobium chrysanthum and its anti-inflammatory activities Bioorg Med Chem 2006 14 3496 3501 16431116 123 Pengpaeng P Sritularak B Chanvorachote P Dendrofalconerol A suppresses migrating cancer cells via EMT and integrin proteins Anticancer Res 2015 35 201 205 25550552 124 Fan C Wang W Wang Y Qin G Zhao W Chemical constituents from Dendrobium densiflorum Phytochemistry 2001 57 1255 1258 11454354 125 Klongkumnuankarn P Busaranon K Chanvorachote P Sritularak B Jongbunprasert V Likhitwitayawuid K Cytotoxic and antimigratory activities of phenolic compounds from Dendrobium brymerianum Evid Based Complement Alternat Med 2015 2015 350410 25685168 126 Luo A Ge Z Fan Y Luo A Chun Z He X In vitro and in vivo anti-oxidant activity of a water-soluble polysaccharide from Dendrobium denneanum Molecules 2011 16 1579 1592 21321529